Published in Osteoporos Int on October 24, 2016
Variations in the pattern of pubertal changes in boys. Arch Dis Child (1970) 16.22
Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics (2002) 12.32
Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res (1993) 10.98
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol (2009) 8.42
Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul Disord (1991) 6.63
Profiles of neuromuscular diseases. Duchenne muscular dystrophy. Am J Phys Med Rehabil (1995) 2.45
Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study. Lancet (2004) 1.95
Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child (2002) 1.70
Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry. Bone Miner (1992) 1.61
Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study. J Bone Miner Res (2004) 1.32
Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop (2000) 1.28
Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology (2007) 1.21
Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions. J Clin Densitom (2014) 1.21
Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders. J Bone Miner Res (2015) 1.16
Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res (Hoboken) (2012) 1.09
Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol (2002) 1.08
High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol (2012) 1.05
Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul Disord (2007) 1.03
Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int (2011) 1.00
Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Bone Miner Res (2009) 0.90
Duchenne muscular dystrophy: Canadian paediatric neuromuscular physicians survey. Can J Neurol Sci (2010) 0.90
The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy. Osteoporos Int (2012) 0.88
Causes, mechanisms and management of paediatric osteoporosis. Nat Rev Rheumatol (2013) 0.88
Early bisphosphonate treatment in infants with severe osteogenesis imperfecta. J Pediatr (2006) 0.88
Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study. Acta Orthop Belg (2005) 0.87
Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta. Arch Dis Child (2006) 0.86
Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years. J Bone Miner Res (2015) 0.85
Spinal deformity index (SDI) is a good predictor of incident vertebral fractures. Osteoporos Int (2009) 0.85
Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy. Calcif Tissue Int (2000) 0.82
The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures. J Clin Endocrinol Metab (2014) 0.82
Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis. J Clin Endocrinol Metab (2015) 0.80
The management of osteoporosis in children. Osteoporos Int (2016) 0.79
Diagnosis and treatment of pediatric osteoporosis. Curr Opin Endocrinol Diabetes Obes (2014) 0.78
Reversal of vertebral deformities in osteoporosis: measurement error or "rebound"? J Bone Miner Res (1994) 0.78
Osteoporosis in Children with Chronic Disease. Endocr Dev (2015) 0.78
Histomorphometry and Bone Matrix Mineralization Before and After Bisphosphonate Treatment in Boys With Duchenne Muscular Dystrophy: A Paired Transiliac Biopsy Study. J Bone Miner Res (2016) 0.77
The Spectrum of Recovery From Fracture-Induced Vertebral Deformity in Pediatric Leukemia. Pediatr Blood Cancer (2016) 0.77
Risk Factors for First Fractures Among Males With Duchenne or Becker Muscular Dystrophy. J Pediatr Orthop (2015) 0.76
Musculoskeletal health in newly diagnosed children with Crohn's disease. Osteoporos Int (2017) 0.75